Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Politics

Bipartisan senators’ bill would require Congress to approve new tariffs

by admin April 4, 2025
April 4, 2025
Bipartisan senators’ bill would require Congress to approve new tariffs

Two senior lawmakers have introduced a bipartisan bill that would reassert Congress’ powers over U.S. tariffs, a day after President Donald Trump announced a new wide-ranging tariff strategy during his ‘Liberation Day’ speech on Wednesday.

Sens. Chuck Grassley, R-Iowa, and Maria Cantwell, D-Wash., on Thursday introduced the Trade Review Act of 2025, which would require the president to notify Congress about any new tariffs within 48 hours of imposition. 

The bill also requires that Trump provide an explanation of the rationale along with an analysis of the tariffs’ potential impact on the U.S. economy. Congress would have to approve the new tariffs within 60 days or allow them to expire.

If enacted, the bill would shift certain trade policymaking powers from the executive branch to the Congress. 

‘For too long, Congress has delegated its clear authority to regulate interstate and foreign commerce to the executive branch,’ Grassley, a Trump ally who is skeptical of tariffs, said in a statement. 

‘Building on my previous efforts as Finance Committee Chairman, I’m joining Senator Cantwell to introduce the bipartisan Trade Review Act of 2025 to reassert Congress’ constitutional role and ensure Congress has a voice in trade policy,’ he continued.

Cantwell said in a statement that Trump’s tariffs would hurt sectors such as agriculture, manufacturing and technology and have reverberating effects on consumers.

‘Ultimately, consumers will pay the price,’ Cantwell said in a statement. ‘It’s time for Congress to take action to counter the president’s trade war.’

Grassley’s home state of Iowa heavily relies on farm crop exports, while Cantwell’s Washington state is home to many export-heavy companies such as Boeing.

Trump on Thursday compared the tariffs to a medical operation, and said the ‘patient lived, and is healing.’ ‘The prognosis is that the patient will be far stronger, bigger, better, and more resilient than ever before,’ he wrote on Truth Social.

Thursday’s bill was introduced after four Republican senators joined Democrats in approving a separate resolution on Wednesday that would repeal Trump’s emergency declaration levying tariffs on Canadian imports. Grassley was not one of the Republican defectors. The resolution is likely dead on arrival in the House.

This post appeared first on FOX NEWS

previous post
Trump urged to review UN immunity, lax visa rules amid national security concerns
next post
Waltz’s Signal chat woes snowball as Trump admin defends national security advisor

Related Posts

Dem bid to end Trump energy emergency squashed...

February 27, 2025

LEE CARTER: The secret sauce of Trump’s success...

May 7, 2025

FLASHBACK: Ted Cruz predicts ballooning Obamacare subsidies now...

October 23, 2025

Kamala Harris reveals what Biden told her just...

September 21, 2025

Grassley presses FBI over Trump Arctic Frost probe...

January 10, 2026

House GOP unveils healthcare plan ahead of vote...

December 13, 2025

Trump has now been in office for six...

July 20, 2025

Putin backs Trump’s claim that the Ukraine war...

August 17, 2025

This July 4th, a family waits: American hostage’s...

July 5, 2025

JD Vance takes shot at Harris as he...

March 21, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wallstreetwizardry.com | All Rights Reserved